Christopher G Bunick Selected Research

Neoplasms (Cancer)

1/2022	Keratin 1 as a cell-surface receptor in cancer.
1/2020	Successful management of malodor from fungating tumors using crushed metronidazole tablets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher G Bunick Research Topics

Disease

5	Acne Vulgaris 05/2022 - 01/2020
3	Infections 05/2022 - 03/2013
2	Dysbiosis 02/2022 - 04/2021
2	Neoplasms (Cancer) 01/2022 - 01/2020
1	Ichthyosis (Xeroderma) 11/2022
1	Skin Diseases (Skin Disease) 05/2022
1	Hordeolum (Stye) 05/2022
1	Bullous Pemphigoid (Pemphigoid) 05/2022
1	Rosacea (Acne Rosacea) 05/2022
1	Staphylococcal Infections 05/2022
1	Staphylococcal Skin Infections 05/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2021
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 12/2021
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 12/2021
1	Wound Infection (Wound Infections) 04/2021
1	Inflammation (Inflammations) 04/2021
1	Edema (Dropsy) 04/2021
1	Liver Diseases (Liver Disease) 09/2020
1	Alopecia Areata 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Keratitis-Ichthyosis-Deafness Syndrome 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Drug Hypersensitivity Syndrome 11/2016
1	Sarcoidosis (Schaumann Disease) 05/2016
1	Pyoderma 11/2014
1	Exfoliative Dermatitis (Erythroderma) 05/2014
1	Acute Generalized Exanthematous Pustulosis 05/2014
1	Herpes Zoster 03/2013
1	Vaccinia 03/2013
1	Chickenpox 03/2013
1	Folliculitis (Sycosis) 03/2013
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 11/2012
1	Chemical Burns (Chemical Burn) 10/2012
1	Hypertension (High Blood Pressure) 11/2011
1	Postoperative Hemorrhage 11/2011
1	Complementation Group C Xeroderma Pigmentosum 12/2006

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 01/2020
5	Tetracycline (Achromycin)FDA LinkGeneric 05/2022 - 01/2020
5	sarecyclineIBA 05/2022 - 01/2020
3	Keratins (Keratin)IBA 01/2022 - 09/2020
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2006
2	Minocycline (Cyclops)FDA LinkGeneric 02/2022 - 04/2021
2	Doxycycline (Periostat)FDA LinkGeneric 02/2022 - 04/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2016
1	Isotretinoin (Accutane)FDA LinkGeneric 11/2022
1	TetracyclinesIBA 05/2022
1	Cell Surface ReceptorsIBA 01/2022
1	Keratin-1IBA 01/2022
1	Keratin-8 (Keratin 8)IBA 09/2020
1	Keratin-5 (Keratin 5)IBA 09/2020
1	Biological ProductsIBA 01/2020
1	Metronidazole (Metric)FDA LinkGeneric 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2020
1	TabletsIBA 01/2020
1	ixekizumabIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Connexin 26IBA 01/2019
1	Cyclin D1IBA 01/2018
1	NivolumabIBA 05/2016
1	IpilimumabIBA 05/2016
1	Infliximab (Remicade)FDA Link 11/2014
1	Midodrine (Midon)FDA LinkGeneric 05/2014
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 03/2013
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2012
1	AnticoagulantsIBA 11/2011

Therapy/Procedure

2	Therapeutics 01/2020 - 05/2016
1	Radiotherapy 11/2012